✦ LIBER ✦

257 Long term effects and clinical outcome of low-dose azithromycin in young patients with cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled trial

Book ID: 118640385
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 98 KB
Volume: 4
Category: Article
ISSN: 1569-1993
DOI: 10.1016/s1569-1993(05)80231-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term daily high and low doses of az

Long-term daily high and low doses of azithromycin in children with cystic fibrosis: A randomized controlled trial

✍ S.K. Kabra; R. Pawaiya; Rakesh Lodha; Arti Kapil; Madhulika Kabra; A. Satya Vani 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 200 KB

A placebo-controlled, double-blind trial

A placebo-controlled, double-blind trial of the long-term effects of albuterol administration in patients with cystic fibrosis

✍ Peter König; Jill Poehler; Giulio J. Barbero 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Febuxostat, a novel nonpurine selective

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: A twenty-eight–day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout

✍ Michael A. Becker; H. Ralph Schumacher Jr.; Robert L. Wortmann; Patricia A. MacD 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 3 views

## Abstract ## Objective Gout affects ∼1–2% of the American population. Current options for treating hyperuricemia in chronic gout are limited. The purpose of this study was to assess the safety and efficacy of febuxostat, a nonpurine selective inhibitor of xanthine oxidase, in establishing normal

Long-term safety and maintenance of clin

Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: Extension phase of a randomized, double-blind, placebo-controlled trial

✍ George Nuki; Barry Bresnihan; Moraye B. Bear; Dorothy McCabe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 3 views

Clinical trial: short-term effects of co

Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia – a randomized, double-blind, placebo-controlled study

✍ P. GINÈS; F. WONG; H. WATSON; R. TERG; R. BRUHA; J.-P. ZARSKI; F. DUDLEY; FOR TH 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Positive effect of alendronate on bone m

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial

✍ W. F. Lems; M. C. Lodder; P. Lips; J. W. J. Bijlsma; P. Geusens; N. Schrameijer; 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 123 KB